ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

TRVN Trevena Inc

0.66925
0.05605 (9.14%)
Last Updated: 09:42:27
Delayed by 15 minutes

Period:

Draw Mode:

Volume 43,464
Bid Price 0.6003
Ask Price 0.6695
News -
Day High 0.6695

Low
0.5084

52 Week Range

High
3.28

Day Low 0.60
Company Name Stock Ticker Symbol Market Type
Trevena Inc TRVN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.05605 9.14% 0.66925 09:42:27
Open Price Low Price High Price Close Price Prev Close
0.60 0.60 0.6695 0.6132
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
87 43,464 $ 0.6384685 $ 27,750 - 0.5084 - 3.28
Last Trade Time Type Quantity Stock Price Currency
09:42:27 100 $ 0.66925 USD

Trevena Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
9.26M 15.17M - -418k -53.67M -3.54 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Trevena News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No TRVN Message Board. Create One! See More Posts on TRVN Message Board See More Message Board Posts

Historical TRVN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.580.66950.540.5928885149,9820.0892515.39%
1 Month0.57840.66950.50840.58566989,8310.0908515.71%
3 Months0.70151.030.50840.6184369353,011-0.03225-4.6%
6 Months1.001.120.50840.8511864503,661-0.33075-33.08%
1 Year3.063.280.50842.02973,721-2.39-78.13%
3 Years58.0077.500.508428.211,573,239-57.33-98.85%
5 Years16.15112.500.508439.402,146,036-15.48-95.86%

Trevena Description

Trevena Inc is an American biotechnology company. The portfolio pipeline is focused on medicines targeting pain management: TRV734: oral medicine for moderate to severe pain; TRV250: oral medicine for migraines; and TRV027: treatment for acute heart failure. Its leading product is oliceridine (TRV130), a protein-based chemical meant to manage moderate to severe acute pain.

Your Recent History

Delayed Upgrade Clock